monoisoamyl-2,3-dimercaptosuccinate has been researched along with glutathione disulfide in 5 studies
Studies (monoisoamyl-2,3-dimercaptosuccinate) | Trials (monoisoamyl-2,3-dimercaptosuccinate) | Recent Studies (post-2010) (monoisoamyl-2,3-dimercaptosuccinate) | Studies (glutathione disulfide) | Trials (glutathione disulfide) | Recent Studies (post-2010) (glutathione disulfide) |
---|---|---|---|---|---|
53 | 0 | 19 | 3,285 | 71 | 990 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Flora, SJ; Jaiswal, DK; Kannan, GM; Pant, BP | 1 |
Flora, SJ; Gautam, P; Jatav, PC; Mehta, A; Pathak, U | 1 |
Bhadauria, S; Flora, SJ; Pachauri, V; Yadav, A | 1 |
Dubey, M; Flora, SJ; Kushwaha, P; Pachauri, V; Yadav, A | 1 |
Flora, SJS; Sachdeva, S; Sharma, A | 1 |
5 other study(ies) available for monoisoamyl-2,3-dimercaptosuccinate and glutathione disulfide
Article | Year |
---|---|
Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats.
Topics: Aminolevulinic Acid; Animals; Arsenicals; Chelating Agents; Copper; Drug Therapy, Combination; Gallium; Glutathione; Glutathione Disulfide; Kidney; Liver; Male; Malondialdehyde; Oxalic Acid; Oxidative Stress; Porphobilinogen Synthase; Protoporphyrins; Rats; Rats, Wistar; Spleen; Succimer; Tissue Distribution; Zinc | 2002 |
Essential metal status, prooxidant/antioxidant effects of MiADMSA in male rats: age-related effects.
Topics: Aging; Animals; Antioxidants; Chelating Agents; Copper; Glutathione; Glutathione Disulfide; Hemoglobins; Iron; Magnesium; Male; Metals; Oxidants; Porphobilinogen Synthase; Protoporphyrins; Rats; Rats, Wistar; Succimer; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Zinc | 2007 |
Monoisoamyl 2, 3-dimercaptosuccinic acid (MiADMSA) demonstrates higher efficacy by oral route in reversing arsenic toxicity: a pharmacokinetic approach.
Topics: Administration, Oral; Animals; Arsenic; Arsenic Poisoning; Chelating Agents; Chronic Disease; Copper; Dose-Response Relationship, Drug; Glutathione; Glutathione Disulfide; Kidney; Liver; Liver Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Succimer; Zinc | 2012 |
Monensin potentiates lead chelation efficacy of MiADMSA in rat brain post chronic lead exposure.
Topics: Animals; Antioxidants; Biomarkers; Brain; Chelating Agents; DNA Damage; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Kidney; Lead; Male; Monensin; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2012 |
MiADMSA abrogates sodium tungstate-induced oxidative stress in rats.
Topics: Animals; Antidotes; Arsenic; Biomarkers; Chelating Agents; Glutathione Disulfide; Male; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer; Thiobarbituric Acid Reactive Substances; Tungsten | 2022 |